Dean Carson

Dean Carson is a seasoned professional in the pharmaceutical and biotech industries, currently serving as a Senior Medical Affairs Consultant at Otsuka Pharmaceutical Companies and Principal Consultant at Cade Group, LLC. Previously, Dean held multiple leadership roles, including CEO of Viridia Life Sciences and EmpathBio, both portfolio companies of ATAI Life Sciences, where development focused on innovative treatments for treatment-resistant depression and PTSD, respectively. Dean's extensive experience includes Vice President of Scientific Affairs at Saniona, Managing Director at Vista Point Capital, and founder of Katana Pharmaceuticals. Academic credentials feature a Postdoctoral Fellowship in Psychiatry & Behavioral Sciences from Stanford University School of Medicine and a PhD in Neuropharmacology from the University of Sydney.